| Paula M Trautner, MD | |
|
150 Rock Point Dr Ste B, Durango, CO 81301-7727 | |
| (970) 249-6116 | |
| (970) 249-6116 |
| Full Name | Paula M Trautner |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 150 Rock Point Dr Ste B, Durango, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013084888 | NPI | - | NPPES |
| 01242957 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | AT 1391541 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Paula M Trautner, MD Po Box 462, Silverton, CO 81433-0462 Ph: (970) 249-6116 | Paula M Trautner, MD 150 Rock Point Dr Ste B, Durango, CO 81301-7727 Ph: (970) 249-6116 |
News Archive
Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., announced today that its latest joint venture target, Amarantus BioSciences, Inc., expects to announce the results of a preclinical study evaluating the potential of its new protein therapy as a treatment for Traumatic Brain Injury (TBI).
BIO-key International, Inc., a leader in finger-based biometric identification solutions announced the award of another contract for a fingerprint biometric identity solution built on the fusion of BIO-key and MorphoTrak algorithms. The first contract for this fused solution, awarded to MorphoTrak (a Morpho company) by Lockheed Martin in September 2009, provides fingerprint identification technology for the FBI's Next Generation Identification (NGI) system. This new contract will provide large scale advanced finger matching technology to an overseas customer.
Shire plc, the global specialty biopharmaceutical company, today announced positive top-line results from a Phase 2 study to evaluate the safety and efficacy of Vyvanse (lisdexamfetamine dimesylate) Capsules, (CII) in adults with binge eating disorder.
Sunshine Biopharma Inc., a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed a detailed cytotoxicity study of its lead compound, Adva-27a, in MCF-7/MDR, a Multidrug Resistant Breast Cancer cell line.
Elekta updated the market this morning on its latest research and development initiatives, with special focus on Atlantic, the first generation high field MRI-guided radiation therapy system. The company unveiled plans to introduce this game-changing technology in 2017 and deliver the first systems in 2018.
› Verified 7 days ago
Dr. Susan Grayson, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 303 Blue Spruce Trl, Durango, CO 81301 Phone: 970-259-0321 | |
Patti Lynn Snodgrass, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 281 Sawyer Dr, Suite 100, Durango, CO 81303 Phone: 970-259-2162 Fax: 970-247-5255 | |
Dr. Mark A Braunstein, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2855 Main Ave Suite A105, Four Courners Mental Health, Llc, Durango, CO 81301 Phone: 970-382-6690 Fax: 970-382-0207 | |
Mark David Fallon-cyr, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 281 Sawyer Dr, Suite 100, Durango, CO 81303 Phone: 970-259-2162 Fax: 970-247-0455 | |
Steve Kitson, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 281 Sawyer Dr, Durango, CO 81303 Phone: 970-259-2162 | |
David Rushworth, M.D., PH.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 555 Rivergate Ln Ste B1-102, Durango, CO 81301 Phone: 970-844-2865 Fax: 970-837-3111 |